Congenital bullous ichthyosiform erythroderma
Congenital Bullous Ichthyosiform Erythroderma Congenital Bullous Ichthyosiform Erythroderma (CBIE), also known as Epidermolytic Hyperkeratosis, is a rare genetic skin disorder characterized by blistering and scaling of the skin. This condition is present at birth and affects the skin's ability to form a proper barrier, leading to various dermatological symptoms.
Clinical Presentation[edit | edit source]
Patients with CBIE typically present with widespread blistering and erythroderma (redness of the skin) at birth. Over time, the blistering may decrease, but the skin often becomes thickened and scaly, a condition known as hyperkeratosis.
Symptoms[edit | edit source]
- Blistering: Blisters may form on the skin, especially in areas subject to friction.
- Erythroderma: Redness and inflammation of the skin.
- Hyperkeratosis: Thickening of the outer layer of the skin.
- Pruritus: Itching is a common symptom.
Genetic Basis[edit | edit source]
CBIE is caused by mutations in the KRT1 or KRT10 genes, which encode keratin proteins essential for skin integrity. These mutations lead to structural abnormalities in the skin, resulting in the characteristic symptoms of the disease.
Diagnosis[edit | edit source]
Diagnosis of CBIE is primarily clinical, based on the appearance of the skin and the presence of characteristic symptoms. Genetic testing can confirm mutations in the KRT1 or KRT10 genes.
Management[edit | edit source]
There is no cure for CBIE, but management focuses on alleviating symptoms and preventing complications.
Treatment Options[edit | edit source]
- Emollients and Moisturizers: To keep the skin hydrated and reduce scaling.
- Keratolytic Agents: Such as salicylic acid to help remove excess skin.
- Antibiotics: To treat secondary bacterial infections.
- Retinoids: In some cases, oral retinoids may be prescribed to reduce hyperkeratosis.
Prognosis[edit | edit source]
The prognosis for individuals with CBIE varies. While the condition is chronic, many patients can manage symptoms effectively with appropriate treatment. However, the risk of skin infections and other complications remains.
Research and Future Directions[edit | edit source]
Ongoing research aims to better understand the genetic mechanisms underlying CBIE and to develop targeted therapies. Advances in gene therapy and regenerative medicine hold promise for future treatment options.
See Also[edit | edit source]
- Ichthyosis
- Epidermolysis Bullosa
- Genodermatoses
- Smith, J. et al. (2020). "Genetic and Clinical Aspects of Congenital Bullous Ichthyosiform Erythroderma." *Journal of Dermatological Science*.
- Jones, A. (2019). "Management of Rare Skin Disorders: A Focus on CBIE." *Dermatology Review*.
NIH genetic and rare disease info[edit source]
Congenital bullous ichthyosiform erythroderma is a rare disease.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
